Lonza plots 2 manufacturing suites for antibody-drug conjugates at Switzerland site kblankenship Wed, 12/02/2020 – 09:49
Category: Uncategorized
To develop effective therapeutics against pathogens, scientists need to first uncover how they attack host cells. An efficient […]
Agreement will aim to develop a platform to support radiologists’ decision-making
IgE blocker approved as an add-on treatment for adult patients
Companies have signed development and commercialisation agreement
Pfizer, BioNTech nabs COVID-19 vaccine authorization from U.K. for first-ever marketed mRNA shot aliu Wed, 12/02/2020 – 04:34
First doses for emergency use will be delivered ‘immediately’
Updated Date: Tue, 24 Nov 2020 00:00:00 EST
Updated Date: Tue, 24 Nov 2020 00:00:00 EST
